NO20072895L - Topiske sammensetninger inneholdende myrica gale olje - Google Patents

Topiske sammensetninger inneholdende myrica gale olje

Info

Publication number
NO20072895L
NO20072895L NO20072895A NO20072895A NO20072895L NO 20072895 L NO20072895 L NO 20072895L NO 20072895 A NO20072895 A NO 20072895A NO 20072895 A NO20072895 A NO 20072895A NO 20072895 L NO20072895 L NO 20072895L
Authority
NO
Norway
Prior art keywords
myrica
oil
mad
compositions containing
topical compositions
Prior art date
Application number
NO20072895A
Other languages
English (en)
Inventor
Christopher Francis Smith
Edward Galley
Eilidh Ruth Benest
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO20072895L publication Critical patent/NO20072895L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anvendelse av Myrica gale olje i produksjonen av en sammensetning for behandlingen av huden eller andre eksponerte overflater av kroppen er beskrevet. Sammensetninger fremstilt i henhold til oppfinnelsen er særlig egnet som anti-kvise, anti-aldring, antiflass og hudberoligende produkter. Myrica gale olje kan bli brukt med andre aktive forbindelser som har komplementære fordeler, eller som fungerer synergistisk med Myrica gale olje for å produsere et særlig effektivt produkt.
NO20072895A 2004-11-11 2007-06-06 Topiske sammensetninger inneholdende myrica gale olje NO20072895L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424891A GB0424891D0 (en) 2004-11-11 2004-11-11 Topical compositions
PCT/GB2005/000016 WO2006051246A1 (en) 2004-11-11 2005-01-05 Topical compositions comprising myrica gale oil

Publications (1)

Publication Number Publication Date
NO20072895L true NO20072895L (no) 2007-07-10

Family

ID=33523538

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072895A NO20072895L (no) 2004-11-11 2007-06-06 Topiske sammensetninger inneholdende myrica gale olje

Country Status (6)

Country Link
US (1) US20080069898A1 (no)
EP (2) EP1809309A1 (no)
CA (2) CA2586873C (no)
GB (1) GB0424891D0 (no)
NO (1) NO20072895L (no)
WO (1) WO2006051246A1 (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2410587T3 (es) 2004-01-22 2013-07-02 University Of Miami Formulaciones tópicas de coenzima Q10 y métodos de uso
US20110129552A1 (en) * 2009-12-01 2011-06-02 Laderma Pty Ltd Acne Treatment
US8128916B2 (en) * 2005-06-16 2012-03-06 L'oréal Aqueous fatty quaternary amine-containing carrier systems for water-insoluble materials
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
MX337408B (es) 2007-03-22 2016-03-03 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
JP2011521886A (ja) * 2007-06-01 2011-07-28 ガルデルマ・リサーチ・アンド・デヴェロップメント 新規保湿剤およびその使用
FR2925299A1 (fr) * 2007-12-21 2009-06-26 Oreal Utilisation de composition a base de peroxyde pour ameliorer l'aspect de la peau
WO2009126764A1 (en) 2008-04-11 2009-10-15 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
US20110091572A1 (en) * 2008-06-05 2011-04-21 Davidson Richard E Acne treatment compositions comprising nanosilver and uses
US20090312224A1 (en) * 2008-06-13 2009-12-17 Conopco, Inc., D/B/A Unilever Method of Reducing Viscosity of Concentrated Liquid Cleansers by Selection of Perfume Components
US7833289B1 (en) 2009-04-15 2010-11-16 Alterna Holdings Corporation Hair care component and method of manufacture for use in a hair coloring system
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
EA023913B1 (ru) * 2009-05-11 2016-07-29 БЕРГ ФАРМА ЭлЭлСи Способы лечения метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
KR101907411B1 (ko) 2010-03-12 2018-10-12 베르그 엘엘씨 코엔자임 Ｑ10(ＣｏＱ10)의 정맥내 제형 및 이의 사용 방법
CA2792857A1 (en) * 2010-03-17 2011-09-22 Arbonne International Llc Topical skin care composition
CN103608323B (zh) 2011-04-04 2016-08-17 博格有限责任公司 治疗中枢神经系统肿瘤的方法
CN107095863A (zh) 2011-06-17 2017-08-29 博格有限责任公司 可吸入药物组合物
FR2978041B1 (fr) 2011-07-21 2014-01-10 Lvmh Rech Solution parfumante stabilisee vis-a-vis des rayons ultraviolets
FR2978037B1 (fr) 2011-07-21 2014-01-10 Lvmh Rech Additif anti-ultraviolet comprenant un filtre uva, un filtre uvb et une huile solvant desdits filtres, son utilisation dans des compositions colorees et/ou parfumees.
ITRM20110400A1 (it) * 2011-07-27 2013-01-28 Uni Politecnica Delle Marche Nuove composizioni per la protezione solare.
KR102092977B1 (ko) 2011-12-19 2020-03-24 마리 케이 인코포레이티드 피부톤 향상을 위한 식물 추출물의 조합물
WO2013149323A1 (en) * 2012-04-02 2013-10-10 Ntegrity Natural products for skin care
DE102012210379A1 (de) * 2012-06-20 2013-12-24 Beiersdorf Ag Kosmetische und dermatologische Zubereitung enthaltend eine oder mehrere Substanz(en), die das Gen / Protein für den Rezeptor Endo180 modulieren
US20140010896A1 (en) * 2012-07-09 2014-01-09 Cynthia M. Chapman Composition for removing a tick and providing relief
US9433587B2 (en) 2013-03-01 2016-09-06 Envy Medical, Inc. Acne solution
US9295723B2 (en) 2013-03-01 2016-03-29 Envy Medical, Inc. Acne solution
US12440530B2 (en) 2013-03-01 2025-10-14 Envy Medical, Inc. Skin solution with solubilized bakuchiol
EP2983654B1 (en) 2013-04-08 2025-11-12 BPGbio, Inc. Treatment of cancer using coenzyme q10 combination therapies
US9724285B1 (en) * 2013-07-17 2017-08-08 Skindinavia, Inc. Use of stabilized vitamin B-6 (pyridoxine cyclic phosphate) in conjunction with skin cosmetics
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
CA2946124A1 (en) * 2014-04-21 2015-10-29 Envy Medical, Inc. Acne solution
CN105109275A (zh) * 2015-08-18 2015-12-02 潘啟国 一种矿山用地跑轮
EP3162409A1 (en) 2015-10-28 2017-05-03 The Procter and Gamble Company Method to provide hair shine and compositions to be used therein
EP3162408A1 (en) 2015-10-28 2017-05-03 The Procter and Gamble Company Hair shine composition and method of use
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
TW201729796A (zh) * 2016-02-17 2017-09-01 Ａａｋ美國股份有限公司 多功能結構性縮水甘油的／非縮水甘油的基質
EP3468530A4 (en) * 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
EP3684477B1 (fr) * 2018-01-09 2022-03-02 Tomcat International Limited Compositions utiles pour le traitement cosmétique des peaux grasses
WO2019220203A1 (en) * 2018-05-18 2019-11-21 Kancor Ingredients Ltd Anti-dandruff composition
IT201900006493A1 (it) * 2019-05-02 2020-11-02 Alberto Denis Tombolato Crema dermatologica per il trattamento e la prevenzione di affezioni cutanee in campo oncologico
CN110731991B (zh) * 2019-07-30 2025-09-26 浙江养生堂天然药物研究所有限公司 具有祛痘功效的皮肤外用组合物
CN113350225B (zh) * 2020-03-04 2023-05-26 弘光科技大学 防晒精油组合物
JP2024162159A (ja) * 2023-05-09 2024-11-21 ロート製薬株式会社 外用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85111A1 (fr) * 1983-12-01 1985-09-12 Oreal Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
GB2224934B (en) 1988-11-22 1992-01-08 Angus Erskine Stuart A new insect repellent of herbal origin
RU2082392C1 (ru) * 1994-06-29 1997-06-27 Евгения Яковлевна Яковенко Средство для ухода за волосами
FR2735026B1 (fr) * 1995-06-07 1997-08-22 Fabre Pierre Dermo Cosmetique Composition capillaire comprenant un extrait de myrte, son procede de preparation et son utilisation notamment pour un traitement antipelliculaire.
JPH0987619A (ja) * 1995-09-28 1997-03-31 Sanei Gen F F I Inc 酸化防止剤の製造法
FR2741265B1 (fr) * 1995-11-17 1998-12-31 Fabre Pierre Dermo Cosmetique Association extrait de myrte et antifongiques
FR2773711B1 (fr) * 1998-01-16 2001-05-04 Andre Pierre Morice Composition comprenant du miel, au moins une huile essentielle et/ou au moins un derive d'une huile essentielle
FR2783425B1 (fr) * 1998-09-17 2002-06-07 Fabre Pierre Dermo Cosmetique Extrait de myrte titre en myrtucommulone b', son procede de preparation et son application en dermatologie et en cosmetologie
CN1329453C (zh) * 2000-09-11 2007-08-01 三荣源有限公司 提纯的胭脂虫红色料和生产它的方法
GB2362574B (en) * 2001-01-12 2002-04-24 Angus Erskine Stuart A formulation for the destruction of the eggs of chicken mites (Dermanyssus Gallinae)
CA2449943A1 (en) * 2001-06-15 2002-12-27 Kyowa Hakko Kogyo Co., Ltd. Preventives or remedies for arthritis
GB0224992D0 (en) * 2002-10-16 2002-12-04 Somerville Marie Insect repellent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Also Published As

Publication number Publication date
CA2801903A1 (en) 2006-05-18
EP1809309A1 (en) 2007-07-25
CA2586873A1 (en) 2006-05-18
EP2070509A2 (en) 2009-06-17
WO2006051246A1 (en) 2006-05-18
CA2586873C (en) 2013-03-19
US20080069898A1 (en) 2008-03-20
EP2070509A3 (en) 2009-08-05
GB0424891D0 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
PH12020550216A1 (en) Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
MX2022014942A (es) Nuevos compuestos.
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
WO2018136264A9 (en) Pyridine compounds as allosteric shp2 inhibitors
HK1244616A2 (zh) 一组保湿组合及其在制备保湿化妆品的应用
EA200870019A1 (ru) Лактамовые соединения и способы их применения
BR122020010667B8 (pt) inibidores de quinase, seus usos, e composição farmacêutica
MX2009009623A (es) Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide.
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
DK2358717T3 (da) Aminotetrahydropyraner som dipeptidylpeptidase-iv-inhibitorer tilbehandling eller forebyggelse af diabetes
MA33838B1 (fr) Forme amorphe et cristalline de l'hémitartrate de genz 112638 au titre d'inhibiteur de la glucosylcéramide synthétase
EP2070509A3 (en) The use of Myrica gale oil
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
MX2010009401A (es) Forma cristalina de derivado de fenilamino pirimidina.
WO2012154122A3 (en) A topical formulation for treatment of hyperkeratotic skin
WO2012112796A3 (en) Perfluoro(n-butylcyclohexane) compositions and uses thereof
NZ630830A (en) Benzamides
EA201370191A1 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ МОДУЛЯТОРЫ ФАКТОРА КОАГУЛЯЦИИ VIIa, И ИХ ПРИМЕНЕНИЕ
EA201591180A1 (ru) Составы ингибитора lfa-1
ATE524486T1 (de) Lys-thr-dipeptide und deren verwendung
BR112015006063A2 (pt) compostos heteroaromáticos, processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
PT1871374E (pt) Pirazinossulfonamidas substituídas
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
SG194410A1 (en) Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
EA201290485A1 (ru) Производные бензамида

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application